BDSX · Biodesix Inc · Executive Compensation
$22.46
+0.51 (+2.32%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$231.60M
Shares
10.55M
Volume · Oct 28
72.61K
Avg daily vol (3M)
102.43K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Scott Hutton | President and Chief Executive Officer | $2,238,470 |
| Kieran O'Kane | Chief Commercial Officer | $1,007,292 |
| Robin Harper Cowie | Chief Financial Officer, Secretary and Treasurer | $962,001 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Scott Hutton | President and Chief Executive Officer | $2,084,873 |
| Kieran O'Kane | Chief Commercial Officer | $900,645 |
| Robin Harper Cowie | Chief Financial Officer, Secretary and Treasurer | $875,536 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Scott Hutton | President and Chief Executive Officer | $2,290,546 |
| Robin Harper Cowie | Chief Financial Officer, Secretary and Treasurer | $844,367 |
| Kieran O'Kane | Chief Commercial Officer | $672,666 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jack Schuler | director of the Board | Resigned | 2025-04-17 |
| Charles Watts, M.D. | director of the Board | Resigned | 2025-04-17 |
| Christopher Vazquez | Chief Accounting Officer | Appointed | 2023-06-06 |
| Ryan Siurek | Chief Accounting Officer | Resigned | 2023-06-06 |
| Lawrence (Lair) T. Kennedy | Director | Appointed | 2022-12-16 |
Leadership
- Christopher Vazquez Chief Accounting Officer
- Dr. Jon Faiz Kayyem Board Member
- Lawrence (Lair) T. Kennedy Board Member